CERO THERAPEUTICS HOLDINGS, INC. (ticker: CERO) is an OTC-listed clinical research company. DredgeCap's structured extraction of CERO's SEC filings surfaces 10 active risk signals, including 7 late-filing signals, 2 auditor-change signals, and 1 delisting/deregistration signal. CERO reported no tagged revenue in revenue and -$19.92M for the period ending 2025-12-31, with operating cash flow of -$16.10M. Cash and equivalents stood at $1.70M (down 9.6% year-over-year). Total assets of $3.64M are exceeded by total liabilities of $9.09M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
CERO Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for CERO THERAPEUTICS HOLDINGS, INC. (CERO) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.